Circulating neuroendocrine markers in patients with prostate carcinoma

This publication has 24 references indexed in Scilit:

• Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: Neuroendocrine expression in patients untreated and treated with androgen deprivation therapy
  The Prostate, 1998
• Neuroendocrine differentiation in prostatic carcinoma: An update
  The Prostate, 1998
• Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status
  The Prostate, 1998
• Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostate
  Urology, 1996
• The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long‐term follow‐up study with patients treated by radical prostatectomy
  International Journal of Cancer, 1995
• Do neuroendocrine cells in human prostate cancer express androgen receptor?
  Histochemistry and Cell Biology, 1993
• Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
  Cancer, 1993
• Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications
  Cancer, 1992
• Prostatic Carcinoma: Histological and Immunohistological Factors Affecting Prognosis
  British Journal of Urology, 1990
• The course of neuroendocrine differentiation in prostatic carcinomas
  Pathology - Research and Practice, 1989